The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of FDA drug approvals on a thoracic oncology program’s clinical trial enrollment in 2015.
 
Alice Huai-Yu Li
No Relationships to Disclose
 
Jonathan Wade Goldman
Honoraria - Clovis Oncology; Genentech
Research Funding - ArQule; Astex Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Lilly; Synta
 
Marshall L. Spiegel
No Relationships to Disclose
 
Carlos R. Adame
No Relationships to Disclose
 
Courtney L. Wells
No Relationships to Disclose
 
Aaron Elliott Lisberg
No Relationships to Disclose
 
Jennifer L. Strunck
No Relationships to Disclose
 
Sina Famenini
No Relationships to Disclose
 
James M. Carroll
No Relationships to Disclose
 
D. Andrew Tucker
No Relationships to Disclose
 
Ariana R. Hardy
No Relationships to Disclose
 
Karolyn K. Morris
No Relationships to Disclose
 
Paulina J. Linares
No Relationships to Disclose
 
Lauren Sauer
No Relationships to Disclose
 
Deborah Jean Lee Wong
No Relationships to Disclose
 
Blanca A. Ledezma
No Relationships to Disclose
 
Melody A. Mendenhall
No Relationships to Disclose
 
Meghan B. Brennan
No Relationships to Disclose
 
Christina DiLauro Abaya
No Relationships to Disclose
 
Edward B. Garon
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)